腹腔镜辅助治疗横降结肠癌的短期与长期疗效及安全性  

Short term and long-term efficacy and safety of laparoscopic adjuvant treatment for transverse and descending colon cancer

作　　者：孙坤[1] SUN Kun(Chongzhou People's Hospital,Chengdu,Sichuan 611230,China)

机构地区：[1]崇州市人民医院,四川成都611230

出　　处：《中国国境卫生检疫杂志》2023年第S01期74-76,共3页Chinese Journal of Frontier Health and Quarantine

摘　　要：目的探究横、降结肠癌外科手术治疗中,腹腔镜辅助治疗的长短期疗效与安全性。方法研究对象42例横降结肠癌患者,按照随机双盲法分组,对照组(n=21)和实验组(n=21);外科手术治疗时,分别予以2组OC(传统开放结肠切除术)和LAC(腹腔镜辅助结肠切除术治疗),观察对比2组临床疗效;研究起止时间2017年6月-2019年6月。结果实验组较对照组,手术时间较长,术中失血量较少,首次排气时间较早,住院时间较短;组间上述指标对比差异较大(P<0.05)。2组均无死亡案例,2术后并发症发生率、肿瘤复发、随访5年生存率差异较小(P>0.05)。结论横、降结肠癌治疗中,腹腔镜辅助治疗的长短期疗效较佳。Objective To explore the short-term efficaey and safety of laparoscopic assisted treatment in the surgical treatment of transverse and descending colon cancer.Methods 42 patients with transverse descending colon cancer were randomly divided into control group(n=21)and experimental group(n=21).During surgical treatment,two groups of OC(raditional open colectomy)and LAC(laparoscopie asted colectomy)were administered,and the clinical efficacy of the two groups was observed and compared.The research started and ended from June 2017 to June 2019.Results The experimental group had longer surgical time,less intraoperative blood loss,earlier first exhaust time,and shorter hospital stay compared to the control group;There was a signifcant difference in the comparison of the above indicators between groups(P<0.05).There were no deaths in both groups,aund there was a small difference in the incidence of postoperative complications,tumor recurrence,and 5-year follow-up survival rate between the two groups(P>0.05).Conclusion In the treatment of transverse and descending colon cancer,laparoscopic adjuvant therapy has better long-term and short-term effects.

关 键 词：横降结肠癌 腹腔镜 结肠切除术 

分 类 号：R735.35[医药卫生—肿瘤]